Prostaglandin-endoperoxide synthase 2 (PTGS2) rs20417 polymorphism and prostate cancer risk: a meta analysis

被引:0
|
作者
Zhang, Lei [1 ]
Zhang, Yan [1 ,2 ]
Zhang, Xu [1 ]
Hong, Baofa [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing 100853, Peoples R China
[2] 305 Hosp PLA, Dept Urol, Beijing, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2015年 / 8卷 / 11期
关键词
PTGS2; polymorphism; rs20417; prostate cancer; THERAPEUTIC IMPLICATIONS; GENETIC-VARIATION; CYCLOOXYGENASE-2; METAANALYSIS; EXPRESSION; COX-2; SUSCEPTIBILITY; PROLIFERATION; TECHNOLOGIES; PREVENTION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Genetic variation of SNPs in the PTGS2 gene is reported to be capable of creating tissue milieu favoring tumorigenesis. Some studies have implicated the common SNP rs20417 has association with PCa risk, while others showed reverse results. The study was performed with an aim to reconcile the existing controversy by performing a meta-analysis. Methods: We searched databases of Embase and PubMed and identified 8 publications fulfilling the specified inclusion criteria. X-2-based Q-test and I2 statistic were quantified to measure the heterogeneity across studies. The pooled ORs and 95% CIs were calculated to estimate the association between SNP rs20417 and PCa risk. Results: Based on an enlarged sample size by combining the data from published meta-analyses and those missed in them, the results of the present meta-analysis revealed the association of SNP rs20417 and overall PCa risk was not significant. Subgroup analyses according to ethnicity and source of controls did not show any significant results, either. Conclusions: The meta-analysis suggests that the presence of SNP rs20417 is unlikely to be associated with PCa risk. Our understanding of the genetic risk for PCa should be further expanded and refined through future research in a much larger number of participants.
引用
收藏
页码:20454 / 20462
页数:9
相关论文
共 50 条
  • [21] Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility Evidence from 15 case-control studies
    Chen, Shimin
    Chen, Lu
    Tan, Yuling
    Wang, Jiehong
    MEDICINE, 2019, 98 (18)
  • [22] In vitro functional characterization of prostaglandin-endoperoxide synthase 2 during chondrocyte hypertrophic differentiation
    Li, Na
    Wang, Qian
    Zhu, Ting
    Qiao, Longwei
    Zhang, Fei
    Mi, Rui
    Wang, Bo
    Chen, Lin
    Gu, Junxia
    Lu, Yaojuan
    Zheng, Qiping
    ONCOTARGET, 2016, 7 (24) : 36280 - 36292
  • [23] PTGS2 polymorphism rs689466 favors breast cancer recurrence in obese patients
    Freitas-Alves, Daniely Regina
    Vieira-Monteiro, Hayra de Andrade
    Piranda, Diogo Nascimento
    Sobral-Leite, Marcelo
    Lopes da Silva, Taiana Sousa
    Bergmann, Anke
    Valenca, Samuel Santos
    Perini, Jamila Alessandra
    Vianna-Jorge, Rosane
    ENDOCRINE-RELATED CANCER, 2018, 25 (03) : 351 - 365
  • [24] An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition
    Ross, Jason
    Lockett, Linda
    Brookes, Diana
    Tabor, Bruce
    Duesing, Konsta
    Buckley, Michael
    Lockett, Trevor
    Molloy, Peter
    Macrae, Finlay
    Young, Graeme
    Blanco, Ignacio
    Capella, Gabriel
    Hannan, Garry N.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (12) : 1389 - 1395
  • [25] Prostaglandin-endoperoxide synthase 2 is not required for preimplantation ovine conceptus development in sheep
    O'Neil, Eleanore, V
    Brooks, Kelsey
    Burns, Gregory W.
    Ortega, Martha S.
    Denicol, Anna C.
    Aguiar, Luis H.
    Pedroza, Gabriela H.
    Benne, Joshua
    Spencer, Thomas E.
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2020, 87 (01) : 142 - 151
  • [26] Association between the 8473T>C Polymorphism of PTGS2 and Prostate Cancer Risk: A Metaanalysis Including 24,716 Subjects
    Yang, Xueling
    Li, Bo
    Si, Tongguo
    Liu, Ya
    Guo, Zhi
    ONKOLOGIE, 2013, 36 (04): : 182 - +
  • [27] Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin
    Kim, Jong Gwang
    Chae, Yee Soo
    Sohn, Sang Kyun
    Moon, Joon Ho
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Kum, YoonSeop
    Jeon, Seong Woo
    Lim, Kyoung-Hoon
    Kang, Byung-Mo
    Park, In-Ja
    Choi, Gyu Seog
    Jun, Soo-Han
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (05) : 953 - 960
  • [28] Prognostic Significance of Prostaglandin-Endoperoxide Synthase-2 Expressions in Human Breast Carcinoma: A Multiomic Approach
    Saindane, Madhuri
    Rallabandi, Harikrishna Reddy
    Park, Kyoung Sik
    Heil, Alexander
    Nam, Sang Eun
    Yoo, Young Bum
    Yang, Jung-Hyun
    Yun, Ik Jin
    CANCER INFORMATICS, 2020, 19
  • [29] Testosterone induction of prostaglandin-endoperoxide synthase 2 expression and prostaglandin F2α production in hamster Leydig cells
    Matzkin, Maria E.
    Gonzalez-Calvar, Silvia I.
    Mayerhofer, Artur
    Calandra, Ricardo S.
    Frungieri, Monica B.
    REPRODUCTION, 2009, 138 (01) : 163 - 175
  • [30] Hormonal Therapy Deregulates Prostaglandin-Endoperoxidase Synthase 2 (PTGS2) Expression in Endometriotic Tissues
    Santulli, Pietro
    Borghese, Bruno
    Noel, Jean-Christophe
    Fayt, Isabelle
    Anaf, Vincent
    de Ziegler, Dominique
    Batteux, Frederic
    Vaiman, Daniel
    Chapron, Charles
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (03) : 881 - 890